HealthStream Croissance future
Future contrôle des critères 1/6
HealthStream devrait augmenter ses bénéfices et ses revenus de 10.5% et de 4.9% par an respectivement, tandis que le BPA devrait croître de croître de 10.7% par an.
Informations clés
10.5%
Taux de croissance des bénéfices
10.68%
Taux de croissance du BPA
| Healthcare Services croissance des bénéfices | 20.5% |
| Taux de croissance des recettes | 4.9% |
| Rendement futur des capitaux propres | n/a |
| Couverture par les analystes | Low |
| Dernière mise à jour | 21 Jul 2026 |
Mises à jour récentes de la croissance future
Article d’analyse • Nov 06
Earnings Beat: HealthStream, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
It's been a good week for HealthStream, Inc. ( NASDAQ:HSTM ) shareholders, because the company has just released its...Article d’analyse • Feb 27
HealthStream, Inc. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next
Shareholders might have noticed that HealthStream, Inc. ( NASDAQ:HSTM ) filed its yearly result this time last week...Recent updates
Mise à jour du récit • Jul 22
HSTM: Higher P/E Outlook And Capital Returns Will Support Future Upside
HealthStream's fair value estimate has been updated from $30.50 to $33.50 as analysts factor in a revised P/E outlook and recent price target increases that reflect adjusted expectations ahead of upcoming earnings. Analyst Commentary Recent Street research on HealthStream offers a mixed picture, with some analysts updating models and price targets ahead of upcoming earnings.
Mise à jour du récit • Jun 13
HSTM: Buybacks And Updated Assumptions Will Shape Balanced Future Share Performance
Analysts have raised their price target on HealthStream by $3. They cite updated views on its fair value and revised assumptions for the discount rate, revenue growth, profit margins, and future P/E.Mise à jour du récit • May 30
HSTM: AI Disruption Risks And Buybacks Will Shape Future Share Performance
Analysts have raised their fair value estimate for HealthStream from $21.00 to $24.00, citing updated views on the company’s discount rate, revenue growth, profit margins, and future P/E assumptions reflected in recent Street research. Analyst Commentary Street research around HealthStream has become more mixed, even as some firms lift price targets.Mise à jour du récit • Apr 22
HSTM: AI Disruption Risks And Capital Returns Will Drive Future Share Performance
Narrative Update on HealthStream Analysts have reset their price target on HealthStream to $21 from $25, citing respectable 4Q'25 results and management's detailed response to AI-related risks. They view this as leaving the company relatively better positioned than many other SaaS peers.Mise à jour du récit • Apr 08
HSTM: AI Risk Positioning And Capital Returns Will Support Upside Potential
Analysts have reduced the fair value estimate for HealthStream from $34.00 to $30.50, citing a lower forward P/E assumption and an increased discount rate, while also referencing recent Street research that trimmed the price target to $21 and highlighted both respectable 4Q'25 results and management's case that the company is relatively well positioned against AI-related risks in SaaS. Analyst Commentary Recent Street commentary on HealthStream focuses on how the company is handling AI related risks in SaaS and what that could mean for valuation and execution.Mise à jour du récit • Mar 25
HSTM: AI Disruption Risks And Capital Returns Will Shape Future Outlook
Analysts have reset their price target on HealthStream to $21, down from $25, after incorporating fresh views on AI-related risks and management's argument that the company is relatively well positioned compared with other SaaS names. Analyst Commentary Bearish analysts have trimmed expectations on HealthStream by cutting the price target to $21 from $25, while maintaining a neutral stance on the shares.Mise à jour du récit • Mar 10
HSTM: AI Risks, Capital Returns And Fair Value Will Shape Outlook
Analysts have reduced their price target on HealthStream to $21 from $25, citing a recalibration of fair value, discount rate and future P/E assumptions, while also highlighting management's view that the business model remains relatively well positioned against rising AI related concerns for SaaS names. Analyst Commentary Bearish analysts are signaling a more cautious stance on HealthStream after the latest quarterly update.Mise à jour du récit • Feb 24
HSTM: Dividend Hike And Buyback Will Support Future Upside Potential
Analysts have kept their $25.00 price target for HealthStream unchanged, citing only slight tweaks to assumptions around the discount rate, revenue growth, profit margin, and future P/E that together do not materially shift their overall view on the stock. What's in the News The board approved a quarterly cash dividend of US$0.035 per share, a 12.9% increase from the prior US$0.031, payable on March 20, 2026, to shareholders of record on March 9, 2026 (company announcement).Mise à jour du récit • Feb 10
HSTM: Fine Tuned Assumptions Will Support Future Upside Potential
Analysts kept their fair value estimate for HealthStream at $25.00, with modest tweaks to inputs such as discount rate, revenue growth, profit margin, and future P/E assumptions. This underpins the unchanged price target and reflects only fine tuning in their models rather than a shift in overall view.Article d’analyse • Feb 07
HealthStream, Inc. (NASDAQ:HSTM) Investors Are Less Pessimistic Than Expected
HealthStream, Inc.'s ( NASDAQ:HSTM ) price-to-earnings (or "P/E") ratio of 28.8x might make it look like a sell right...Mise à jour du récit • Jan 27
HSTM: Share Repurchases And Acquisition Efforts Will Drive Future Upside
Analysts now place their fair value estimate for HealthStream at US$25.00. The updated target reflects small tweaks to discount rate, revenue growth, profit margin, and future P/E assumptions in their models.Mise à jour du récit • Jan 12
HSTM: Share Buybacks And M&A Activity Will Support Future Upside
Analysts have trimmed their fair value estimate for HealthStream from US$28 to about US$25. They cite updated assumptions on discount rates, revenue growth, profit margins, and a lower future P/E multiple in their refreshed models.Article d’analyse • Nov 06
Earnings Beat: HealthStream, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
It's been a good week for HealthStream, Inc. ( NASDAQ:HSTM ) shareholders, because the company has just released its...Article d’analyse • Oct 30
A Look At The Intrinsic Value Of HealthStream, Inc. (NASDAQ:HSTM)
Key Insights Using the 2 Stage Free Cash Flow to Equity, HealthStream fair value estimate is US$29.23 With US$24.60...Seeking Alpha • Jun 04
HealthStream: High-Quality Business At A Fair Price
Summary HealthStream boasts a resilient, founder-led SaaS business model with decades of profitable growth, strong balance sheet, and shareholder-friendly capital returns. Revenue is highly recurring and predictable due to long-term, non-cancelable contracts, with built-in price escalators and industry-leading products recognized by G2. Short-term headwinds include funding cuts, customer bankruptcy, and delayed revenue recognition, prompting a downward revision in 2025 guidance, but technical issues are seen as temporary. Transition to SaaS and platform offerings positions HealthStream for higher margins and future growth, with most products tied to essential, mandatory healthcare requirements. Despite strong fundamentals, the stock remains expensive on a P/E basis but appears fairly valued on a P/S basis; thus, I rated it as HOLD overall, with a small starter position reflecting my long-term confidence in the business. Read the full article on Seeking AlphaArticle d’analyse • May 23
We Discuss Why The CEO Of HealthStream, Inc. (NASDAQ:HSTM) Is Due For A Pay Rise
Key Insights HealthStream's Annual General Meeting to take place on 29th of May Total pay for CEO Bobby Frist includes...Article d’analyse • May 07
HealthStream (NASDAQ:HSTM) Is Doing The Right Things To Multiply Its Share Price
There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...Article d’analyse • Feb 27
HealthStream, Inc. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next
Shareholders might have noticed that HealthStream, Inc. ( NASDAQ:HSTM ) filed its yearly result this time last week...Article d’analyse • Nov 28
Should You Be Adding HealthStream (NASDAQ:HSTM) To Your Watchlist Today?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Article d’analyse • Nov 07
Returns At HealthStream (NASDAQ:HSTM) Are On The Way Up
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...
Nouveau récit • Sep 24
Navigating Temporary Challenges, The Company Sets Its Sights On Long-term Revenue Growth And Market Expansion
Expansion into the health plan market and strong sales pipelines in key products signal potential for revenue growth and customer base diversification.Article d’analyse • Aug 08
HealthStream, Inc.'s (NASDAQ:HSTM) Shareholders Might Be Looking For Exit
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may...Article d’analyse • Jul 17
We Ran A Stock Scan For Earnings Growth And HealthStream (NASDAQ:HSTM) Passed With Ease
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Article d’analyse • Apr 24
HealthStream, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
It's been a good week for HealthStream, Inc. ( NASDAQ:HSTM ) shareholders, because the company has just released its...Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2028 | 361 | N/A | 39 | N/A | 1 |
| 12/31/2027 | 343 | 24 | 42 | 84 | 5 |
| 12/31/2026 | 327 | 22 | 35 | 73 | 5 |
| 3/31/2026 | 312 | 20 | 33 | 63 | N/A |
| 12/31/2025 | 304 | 18 | 31 | 63 | N/A |
| 9/30/2025 | 299 | 21 | 29 | 61 | N/A |
| 6/30/2025 | 295 | 20 | 31 | 62 | N/A |
| 3/31/2025 | 292 | 19 | 35 | 64 | N/A |
| 12/31/2024 | 292 | 20 | 30 | 58 | N/A |
| 9/30/2024 | 288 | 20 | 32 | 60 | N/A |
| 6/30/2024 | 285 | 18 | 38 | 66 | N/A |
| 3/31/2024 | 283 | 18 | 37 | 64 | N/A |
| 12/31/2023 | 279 | 15 | 36 | 64 | N/A |
| 9/30/2023 | 277 | 13 | 31 | 58 | N/A |
| 6/30/2023 | 274 | 13 | 22 | 49 | N/A |
| 3/31/2023 | 270 | 12 | 24 | 51 | N/A |
| 12/31/2022 | 267 | 12 | 26 | 51 | N/A |
| 9/30/2022 | 263 | 9 | 24 | 49 | N/A |
| 6/30/2022 | 259 | 7 | 20 | 46 | N/A |
| 3/31/2022 | 259 | 6 | 19 | 44 | N/A |
| 12/31/2021 | 257 | 6 | 17 | 42 | N/A |
| 9/30/2021 | 254 | 7 | 18 | 42 | N/A |
| 6/30/2021 | 251 | 8 | 24 | 47 | N/A |
| 3/31/2021 | 247 | 9 | 28 | 49 | N/A |
| 12/31/2020 | 245 | 14 | 17 | 36 | N/A |
| 9/30/2020 | 246 | 17 | 26 | 44 | N/A |
| 6/30/2020 | 247 | 18 | 25 | 43 | N/A |
| 3/31/2020 | 250 | 17 | 30 | 56 | N/A |
| 12/31/2019 | 254 | 14 | N/A | 66 | N/A |
| 9/30/2019 | 251 | 14 | N/A | 67 | N/A |
| 6/30/2019 | 249 | 13 | N/A | 65 | N/A |
| 3/31/2019 | 242 | 14 | N/A | 51 | N/A |
| 12/31/2018 | 232 | 13 | N/A | 43 | N/A |
| 9/30/2018 | 227 | 13 | N/A | 40 | N/A |
| 6/30/2018 | 222 | 12 | N/A | 39 | N/A |
| 3/31/2018 | 218 | 11 | N/A | 39 | N/A |
| 12/31/2017 | 215 | 9 | N/A | 47 | N/A |
| 9/30/2017 | 218 | 5 | N/A | 45 | N/A |
| 6/30/2017 | 222 | 5 | N/A | 47 | N/A |
| 3/31/2017 | 224 | 4 | N/A | 35 | N/A |
| 12/31/2016 | 192 | 5 | N/A | 24 | N/A |
| 9/30/2016 | 223 | 6 | N/A | 24 | N/A |
| 6/30/2016 | 219 | 7 | N/A | 16 | N/A |
| 3/31/2016 | 216 | 7 | N/A | 32 | N/A |
| 12/31/2015 | 209 | 9 | N/A | 35 | N/A |
| 9/30/2015 | 198 | 9 | N/A | 31 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de HSTM ( 10.5% par an) est supérieure au taux d'épargne ( 3.5% ).
Bénéfices vs marché: Les bénéfices de HSTM ( 10.5% par an) devraient croître plus lentement que le marché US ( 16.7% par an).
Croissance élevée des bénéfices: Les bénéfices de HSTM devraient augmenter, mais pas de manière significative.
Chiffre d'affaires vs marché: Le chiffre d'affaires de HSTM ( 4.9% par an) devrait croître plus lentement que le marché de US ( 12.4% par an).
Croissance élevée des revenus: Le chiffre d'affaires de HSTM ( 4.9% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de HSTM devrait être élevé dans 3 ans
Découvrir les entreprises en croissance
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/07/31 10:20 |
| Cours de l'action en fin de journée | 2026/07/30 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
HealthStream, Inc. est couverte par 11 analystes. 5 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Matthew Gillmor | Baird |
| Vincent Colicchio | Barrington Research Associates, Inc. |
| Richard Close | Canaccord Genuity |